Search results for “Pancreatic disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 479 patents, we discovered top 124 key players by total patent application. Olympus Corp., Takeda Pharmaceutical Co., Ltd., InovoBiologic, Inc. are dominant in this area. They take 13.78% of the total patent filing.
Olympus Corp.
Tokyo-to, Japan
Patent: 26
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 23
InovoBiologic, Inc.
British Columbia, Canada
Patent: 17
Huvet Bio, Inc.
South Korea
Patent: 16
DeveloGen AG
Niedersachsen, Germany
Patent: 14
Pharvaris GmbH
Zug, Switzerland
Patent: 14
The General Hospital Corp.
Massachusetts, United States
Patent: 12
Intervet International BV
Noord-Brabant, Netherlands
Patent: 12
Orgenesis Ltd.
Israel
Patent: 11
Novartis AG
Basel-Stadt, Switzerland
Patent: 10
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 145 patents applied in the last 5 years. We discover 52 most active companies in this area. The fast-growing Pharvaris GmbH, The Salk Institute for Biological Studies, Novartis AG take 25.52% of patent filing during this period.
Pharvaris GmbH
Zug, Switzerland
Patent: 14
The Salk Institute for Biological Studies
California, United States
Patent: 13
Novartis AG
Basel-Stadt, Switzerland
Patent: 10
Huvet Bio, Inc.
South Korea
Patent: 10
Alexera AB
Sweden
Patent: 5
MD Healthcare, Inc.
South Korea
Patent: 5
PatoGen AS
Norway
Patent: 3
Dalian University
Liaoning Sheng, China
Patent: 3
Minovia Therapeutics Ltd.
Israel
Patent: 3
Maia Pharmaceuticals, Inc.
New Jersey, United States
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 145 patents in last 5 years, we discover 41 new entrants. Pharvaris GmbH, Novartis AG, Alexera AB are the most active new entrants in this area.
Pharvaris GmbH
Zug, Switzerland
Patent: 14
Novartis AG
Basel-Stadt, Switzerland
Patent: 10
Alexera AB
Sweden
Patent: 5
MD Healthcare, Inc.
South Korea
Patent: 5
PatoGen AS
Norway
Patent: 3
Dalian University
Liaoning Sheng, China
Patent: 3
Minovia Therapeutics Ltd.
Israel
Patent: 3
Maia Pharmaceuticals, Inc.
New Jersey, United States
Patent: 3
Viwit Pharmaceutical Co., Ltd.
Shandong Sheng, China
Patent: 2
IFM Therapeutics
Massachusetts, United States
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 96 patents, we discovered top 23 universities and scientific research institutions by total patent application. The Salk Institute for Biological Studies, Kyoto University, Yale University are dominant in this area. They take 34.38% of the total patent filing.
The Salk Institute for Biological Studies
California, United States
Patent: 20
Kyoto University
Kyoto-fu, Japan
Patent: 7
Yale University
Connecticut, United States
Patent: 6
Tohoku University
Miyagi-ken, Japan
Patent: 5
University of Miami
United States
Patent: 3
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 3
Queen Mary University of London
United Kingdom
Patent: 3
Dresden University of Technology
Sachsen, Germany
Patent: 3
Dalian University
Liaoning Sheng, China
Patent: 3
University of Notre Dame
Indiana, United States
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: